Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential

Author： Scatena Roberto   Bottoni Patrizia   Martorana Giuseppe E   Giardina Bruno  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.7, 2005-07, pp. : 835-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric oxide synthase inhibitors with cardiovascular therapeutic potential

By Hansen Jr. D.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide donor drugs: current status and future trends

By Webb David J   Megson Ian L  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. : 587-601

Informa Healthcare

Access to resources Recommend Favorite

Nitric Oxide Donor Activity of Antihypertensive Drugs Guanoxan, Guanabenz, and Moxonidine

By Danilov A. V.   Azimov V. A.   Levina V. I.   Pyatakova N. V.   Severina I. S.   Grigor'ev N. B.   Granik V. G.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 78-81

Springer Publishing Company

Access to resources Recommend Favorite

Nitric Oxide and Teratogenesis: An Update

By  

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5443-5447

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G   Brock Tommy A   Dixon Richard AF  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite